image of Mary Prahl
  • Telehealth Visits
bch logo

Mary Prahl, MD

Pediatric Infectious Diseases
image of Mary Prahl
image of Mary Prahl
bch logo

Mary Prahl, MD

Pediatric Infectious Diseases
  • Telehealth Visits

On this page

About me

Dr. Mary Prahl is a specialist who cares for children with all types of infectious diseases, including those that are present at birth, affect the bones and joints, develop as a consequence of travel, and occur in immunocompromised individuals.

Prahl's research evaluates immune responses to infectious diseases during early childhood and pregnancy, with the goal of developing new disease-prevention strategies.

Prahl earned her medical degree at the University of Minnesota Medical School. She completed a residency in pediatrics at Northwestern University and the Ann & Robert H. Lurie Children's Hospital of Chicago. She completed a fellowship in pediatric infectious disease at UCSF.

Prahl is a member of the Infectious Diseases Society of America and American Academy of Pediatrics.

Education

Board Certification

  • Pediatric Infectious Disease, American Board of Pediatrics
  • Pediatrics, American Board of Pediatrics

Fellowship

  • Infectious Diseases, UCSF School of Medicine -GME

Residency

  • Pediatrics, Ann & Robert H. Lurie Children's Hospital Chicago

School

  • MD, University of Minnesota Medical School

Academic Title

  • Clinical Professor

Care Keywords

  • Services
    • Pediatric Infectious Diseases

Provider Research Listing

Browse clinical trials and publications by this provider

Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.